Atlas Trials

A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer

Clinical trial NCT00726037 · TERMINATED

Trial details

NCT number
NCT00726037
Sponsor
Loyola University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Pancreatic Cancer
Start date
2008-10-01
Primary completion
2012-01-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.